Frazier Healthcare Partners

Portfolio Co Investors 2026 for Frazier Healthcare Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research.

Frazier Healthcare Partners accounts for 12 tracked companies with verified cap-table data, 12 of which disclose round sizes totalling $1.9B. The median disclosed raise is $135M, and the largest is Tubulis at $575M, ahead of Artiva Biotherapeutics ($198M) and Amunix ($193M).

The names that recur most often on these co-invested cap tables are Frazier Healthcare Partners (12 companies), Redmile Group (4 companies), Casdin Capital (4 companies), Venrock (3 companies), Versant Ventures (3 companies), Longitude Capital (3 companies). By latest disclosed round, the market skews Series A (6), Series B (3), Series C (1), IPO (1).

Best funded Frazier Healthcare Partners companies

  1. Tubulis — $575M (latest: Series A)
  2. Artiva Biotherapeutics — $198M (latest: Series B)
  3. Amunix — $193M (latest: Series B)
  4. Gritstone Oncology — $157M (latest: Series A)
  5. Alcresta — $139M (latest: Series A)
  6. Aptinyx — $135M (latest: Series B)
  7. Hummingbird Bioscience — $125M (latest: Series C)
  8. Akebia Therapeutics — $115M (latest: IPO)
  9. Gritstone bio — $102M (latest: Series A)
  10. Alpine Immune Sciences — $73M
  11. Zavante Therapeutics — $65M (latest: Series A)
  12. Scout Bio — $20M (latest: Series A)

Frazier Healthcare Partners — related firms and companies (54)

Frazier Healthcare Partners profile · All research reports